Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.57 |
| ▸ | MAOB | P27338 | 2/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | BCHE | P06276 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 2/20 | 0.47 |
| ▸ | DRD4 | P21917 | 1/20 | 0.47 |
| ▸ | DRD5 | P21918 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.45 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.45 |
| ▸ | CDK1 | P06493 | 1/20 | 0.45 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.45 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4328518 | 0.86 | MAOA (0.62) | MAOAMAOBSLC6A4CYP1A2CYP2D6 | |
| SCHEMBL25728687 | 0.77 | MAOA (0.68) | MAOAMAOBSLC6A4CYP1A2CYP2D6 | |
| SCHEMBL13928826 | 0.75 | MAOA (0.51) | MAOAMAOBSLC6A4CYP1A2CYP2D6 | |
| SCHEMBL11081316 | 0.74 | MAOA (0.59) | MAOAMAOBSLC6A4CYP1A2CYP2D6 | |
| Bromide SCHEMBL11167461 | 0.74 | MAOA (0.53) | MAOAMAOBSLC6A4CYP1A2CYP2D6 | |
| SCHEMBL24277006 | 0.74 | DRD2 (0.47) | MAOAMAOBSLC6A4DRD1DRD4 | |
| SCHEMBL22680369 | 0.73 | MAPT (0.48) | MAOAMAOBSLC6A4CYP1A2CYP2D6 | |
| SCHEMBL30634713 | 0.73 | MAOB (1.00) | MAOAMAOBSLC6A4DRD1DRD4 | |
| SCHEMBL5525085 | 0.73 | MAOB (1.00) | MAOAMAOBSLC6A4DRD1DRD4 | |
| SCHEMBL20683185 | 0.73 | MAOA (0.77) | MAOAMAOBSLC6A4DRD1DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260053878-A1 | PROCESS FOR EXTRACTION OF ACTIVE COMPOUNDS FROM PLANT BIOMASS | NEURAL THERAPEUTICS INC (CA) | 2026-02-26 | — | — | US | disclosed |
| US-12551519-B2 | Extraction system and method for organic metabolites | VCENNA TECH & LABS INC (CA) | 2026-02-17 | — | — | US | disclosed |
| US-20250162980-A1 | METHODS FOR PREPARING MESCALINE | JOURNEY COLAB CORP. | 2025-05-22 | — | — | US | disclosed |
| US-20240245632-A1 | METHODS OF TREATING SUBSTANCE USE DISORDERS USING MESCALINE | JOURNEY COLAB CORP. | 2024-07-25 | — | — | US | disclosed |
| US-20240123005-A1 | EXTRACTION SYSTEM AND METHOD FOR ORGANIC METABOLITES | Etminan, Seyed Reza (CA) | 2024-04-18 | — | — | US | disclosed |
| WO-2024040358-A1 | PROCESS FOR EXTRACTION OF ACTIVE COMPOUNDS FROM PLANT BIOMASS | NEURAL THERAPEUTICS INC. (CA) | 2024-02-29 | — | — | WO | disclosed |
| WO-2023164178-A2 | METHODS FOR PREPARING MESCALINE | JOURNEY COLAB CORP. (US) | 2023-08-31 | — | — | WO | disclosed |
| WO-2022251690-A1 | MESCALINE FOR THE TREATMENT OF SUBSTANCE USE DISORDERS | JOURNEY COLAB CORP. (US) | 2022-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260053878-A1 | PROCESS FOR EXTRACTION OF ACTIVE COMPOUNDS FROM PLANT BIOMASS | CARM1, CLK4, NPM1 | MAOA 3965/4885MAOB 3868/4885SLC6A4 4821/4885 |
| US-20240245632-A1 | METHODS OF TREATING SUBSTANCE USE DISORDERS USING MESCALINE | SLC6A12, SLC6A3, TPMT | MAOA 364/4885MAOB 320/4885SLC6A4 7/4885 |
| US-20250162980-A1 | METHODS FOR PREPARING MESCALINE | IL4I1, ME3, LIG3 | MAOA 1620/4885MAOB 1420/4885SLC6A4 309/4885 |
| US-12551519-B2 | Extraction system and method for organic metabolites | SHH, WNT1, WNT3A | MAOA 558/4885MAOB 640/4885SLC6A4 2869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.